XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Bitcoin Surges $7,000 Above $87,000
Bitcoin surged more than $7,000 in a single session, climbing from its intraday low to a Bitstamp peak of $87,400, its highest price since late January. The mov...
Ethereum Gains 6% as Binance ETH Withdrawals Hit 3-Year-High Pace
Ethereum gained 6% as ETH withdrawals from Binance reached a pace not seen in three years, with on-chain data pointing to a sharp rise in coins moving off the e...
Whale Alert Reports 138M USDC Transfer From Aave
Whale Alert flagged a transfer of 138 million USDC from the Aave protocol to an unknown wallet, according to the on-chain monitoring service. The movement invol...
Brian Armstrong: Failed CLARITY Act Could Help Coinbase
Armstrong’s position, as reported by CryptoPotatо , centers on the idea that a legislative failure would leave the existing regulatory landscape intact, a lands...
X Partners With Gemini, Kraken & Moomoo for Timeline Trading
X has announced partnerships with Gemini, Kraken, and Moomoo to let users trade directly from the social media timeline, bringing brokerage and crypto exchange...
Bitcoin Hits $87,000 as Crypto Liquidations Top $1 Billion
Bitcoin briefly tapped $87,000 in a sharp upward move that triggered roughly $1 billion in crypto liquidations across derivatives markets, wiping out leveraged...
